heart disease
Singapore-Japanese Tie-Up On Biotech Innovation
A Japanese-Singapore collaboration will focus on the R&D and commercialization of novel clinical approaches for diseases relevant to the Asian population.
People Who Flush After Drinking Face Greater Hypertension Risk
Researchers have found that people who flush after drinking alcohol are at a higher risk for drinking-related hypertension compared to non-flushers.
Mallinckrodt, China Resources Pharma To Promote Optiray X-Ray
Mallinckrodt Pharmaceuticals has partnered with China Resources Pharma to promote its Optiray™ (ioversol injection) x-ray contrast media in China.
Merck Invests €80 Million On Pharmaceutical Facility In China
Merck has invested €80 million into a new pharmaceutical manufacturing facility to be located in the Greater Shanghai region, China.
Cytori, Lorem Vascular To Commercialize Cell-Based Therapies
Cytori and Lorem have announced a partnership to commercialize Cytori Cell Therapy in Asian markets.
Bristol-Myers Squibb, Kyowa Hakko Kirin To Commercialize Coniel In China
Bristol-Myers Squibb and Kyowa Hakko Kirin will commercialize Coniel, a calcium channel blocker for the treatment of hypertension and angina pectoris, in China.
Scientists Study ‘Obesity Paradox’ In Diabetics
People who are obese when they’re diagnosed with type II diabetes have much better survival rates than those with a healthy weight at the time of diagnosis, scientists say.
WHO Report: One In Five Chinese Adults Have Hypertension
Hypertension is a serious public health problem in China affecting at least one in five adults, says a new WHO report.
NTU Spin-Off Amaranth Medical Raises US$20m Series B Financing
Nanyang Technological University spin-off Amaranth Medical has closed a US$20 million Series B financing round led by new investor DCP Management Pte. Ltd.
